Lilly(Eli) & Co

NYSE:LLY   3:59:59 PM EDT
323.05
+5.43 (+1.71%)
Products

FDA Says Approved Olumiant (Baricitinib) Oral Tablets To Treat Adult Patients With Severe Alopecia Areata

Published: 06/13/2022 19:20 GMT
Lilly(Eli) & Co (LLY) - FDA Says Approved Olumiant (baricitinib) Oral Tablets to Treat Adult Patients With Severe Alopecia Areata.
FDA - Granted the Approval of Olumiant to Eli Lilly and Company.
FDA - Olumiant Comes With a Boxed Warning for Serious Infections, Mortality, Malignancy, Major Adverse Cardiovascular Events and Thrombosis.
Further Company Coverage: Llyn ((reuters.
Briefs@thomsonreuters.
Com;)).